Lin Tuo

658 total citations · 1 hit paper
18 papers, 416 citations indexed

About

Lin Tuo is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Lin Tuo has authored 18 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Lin Tuo's work include Liver Disease Diagnosis and Treatment (3 papers), Diet, Metabolism, and Disease (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Lin Tuo is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Diet, Metabolism, and Disease (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Lin Tuo collaborates with scholars based in China, United States and Ecuador. Lin Tuo's co-authors include Ni Tang, Kai Wang, Xuanming Pan, Ailong Huang, Jie Xia, Xiang Jin, Li Liang, Chang Chen, Haijun Deng and Guiji Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Environmental Health Perspectives.

In The Last Decade

Lin Tuo

14 papers receiving 410 citations

Hit Papers

Deficiency of gluconeogenic enzyme PCK1 promotes metaboli... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Tuo China 9 189 131 96 66 58 18 416
Marcelle de Carvalho Ribeiro United States 9 200 1.1× 265 2.0× 53 0.6× 115 1.7× 122 2.1× 11 500
Elisabeth M. Haberl Germany 13 160 0.8× 280 2.1× 56 0.6× 47 0.7× 69 1.2× 31 539
Lin Guan China 12 106 0.6× 71 0.5× 72 0.8× 24 0.4× 48 0.8× 24 307
Zun Xiang China 13 259 1.4× 216 1.6× 211 2.2× 57 0.9× 48 0.8× 17 581
Tonghai Xing China 14 123 0.7× 119 0.9× 48 0.5× 91 1.4× 48 0.8× 28 491
Aveline Filliol France 14 198 1.0× 164 1.3× 61 0.6× 96 1.5× 142 2.4× 22 504
Qinyu Xu China 5 141 0.7× 252 1.9× 39 0.4× 109 1.7× 102 1.8× 9 418
Yusuke Tsuchimoto Japan 10 99 0.5× 153 1.2× 25 0.3× 87 1.3× 83 1.4× 32 350
Anneleen Remmerie Belgium 4 165 0.9× 139 1.1× 50 0.5× 21 0.3× 160 2.8× 4 423
En-De Hu China 7 281 1.5× 234 1.8× 154 1.6× 120 1.8× 53 0.9× 9 564

Countries citing papers authored by Lin Tuo

Since Specialization
Citations

This map shows the geographic impact of Lin Tuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Tuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Tuo more than expected).

Fields of papers citing papers by Lin Tuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Tuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Tuo. The network helps show where Lin Tuo may publish in the future.

Co-authorship network of co-authors of Lin Tuo

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Tuo. A scholar is included among the top collaborators of Lin Tuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Tuo. Lin Tuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Liu, Jingmei, Yingying Han, Yani Zhou, et al.. (2025). Gastroenterologists’ perspectives of high-dose dual therapy for Helicobacter pylori infection in China: Results of a China survey. Medicine. 104(26). e43058–e43058.
3.
Tuo, Lin, et al.. (2024). Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study. Frontiers in Endocrinology. 15. 1315046–1315046. 2 indexed citations
4.
Sun, Yunyan, Jinyan Liu, Dong Zhan, et al.. (2024). Depletion of Tregs from CD4+CAR‐T cells enhances the tumoricidal effect of CD8+CAR‐T cells in anti‐CD19 CAR‐T therapy. FEBS Journal. 292(8). 1904–1919. 2 indexed citations
5.
Tuo, Lin, et al.. (2024). Identifying influential risk spreaders in cryptocurrency networks based on the novel gravity strength centrality model. Applied Economics Letters. 32(19). 2755–2764. 1 indexed citations
6.
Liu, Yi, Guiji Zhang, Haijun Deng, et al.. (2023). Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice. Nature Communications. 14(1). 1402–1402. 90 indexed citations breakdown →
7.
Yan, Liting, Lin Tuo, Tingting Luo, et al.. (2023). Cellular and molecular insights into incomplete immune recovery in HIV/AIDS patients. Frontiers in Immunology. 14. 1152951–1152951. 27 indexed citations
8.
Yang, Kun, Lin Tuo, Xin Tu, et al.. (2023). Urinary Glyphosate, 2,4-D and DEET Biomarkers in Relation to Neurobehavioral Performance in Ecuadorian Adolescents in the ESPINA Cohort. Environmental Health Perspectives. 131(10). 107007–107007. 15 indexed citations
9.
Kim, Beom Kyung, Nobuharu Tamaki, Kento Imajo, et al.. (2022). Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD. Journal of Hepatology. 77(6). 1482–1490. 68 indexed citations
11.
Jin, Xiang, Chang Chen, Rui Liu, et al.. (2021). Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. Journal of Clinical Investigation. 131(8). 85 indexed citations
12.
Jin, Xiang, Yuhong Zhang, Lin Tuo, et al.. (2019). Transcriptomic changes associated with PCK1 overexpression in hepatocellular carcinoma cells detected by RNA-seq. Genes & Diseases. 7(1). 150–159. 8 indexed citations
13.
Tuo, Lin, Xiang Jin, Xuanming Pan, et al.. (2019). PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27Kip1 axis. Journal of Experimental & Clinical Cancer Research. 38(1). 50–50. 58 indexed citations
14.
Tuo, Lin, Xiang Jin, Xuanming Pan, et al.. (2018). PCK1 Downregulation Promotes TXNRD1 Expression and Hepatoma Cell Growth via the Nrf2/Keap1 Pathway. Frontiers in Oncology. 8. 611–611. 41 indexed citations
15.
Meier, Angela, Emilie Gross, Jan M. Schilling, et al.. (2018). Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief Report. Anesthesia & Analgesia. 126(6). 1910–1913. 13 indexed citations
16.
17.
Tuo, Lin, et al.. (2017). [Umbilical cord mesenchymal stem cells and their association with liver fibrosis].. PubMed. 25(1). 65–68. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026